OSR Health shareholders re-elect seven directors, approve proposals at annual meeting

What happened

OSR Health, Inc. (Nasdaq: OSRH), a surgical and medical instruments company based in Bellevue, Washington, held its annual meeting of stockholders on August 7, 2026. The company disclosed the voting results in a Form 8-K filed with the SEC on August 10, 2026.

Shareholders re-elected all seven director nominees: Kuk Hyoun Hwang, Jun Chul Whang, Alcide Barberis, Seng Chin Mah, Hyuk Joo Jee, Joong Myung Cho, and Reto Fierz. Each received between 15.17 million and 15.19 million votes in favor, with fewer than 134,000 votes withheld for any candidate.

Stockholders also approved three other proposals: the ratification of the independent auditor (20.3 million for), the executive compensation proposal (15.1 million for), and a proposal to increase the number of authorized shares of common stock (19.9 million for).

The stock closed at $0.289 on August 10, down 25.13% from the previous close of $0.386, with volume of about 2.8 million shares, more than three times the average.

The filing does not explain the reason for the stock price decline.

The filing

This Form 8-K, filed under Item 5.07 (Submission of Matters to a Vote of Security Holders), reports the outcome of votes taken at the annual meeting. Under SEC rules, companies must disclose shareholder vote results within four business days of the meeting, which is why the filing came out on August 10 for the August 7 meeting.

The company said 35,118,692 shares of common stock were outstanding and entitled to vote as of the record date of July 8, 2026. A total of 21,088,120 shares were present in person or by proxy, representing about 60.05% of the outstanding shares, which constituted a quorum.

The meeting covered four proposals: director elections, auditor ratification, executive compensation (a say-on-pay vote), and an increase in authorized shares. All four passed.

What this means

A Form 8-K is a current report companies file to announce significant events. Item 5.07 is specifically for disclosing shareholder vote results. The 'quorum' is the minimum number of shares that must be present for the meeting to be valid; here, over half of the outstanding shares were represented.

The 'authorized shares increase' proposal means shareholders approved raising the maximum number of shares the company is allowed to issue. This does not mean new shares have been issued yet, but it gives the company flexibility to do so in the future — often for raising capital or for stock-based compensation.

The executive compensation vote is non-binding — it is an advisory 'say-on-pay' that lets shareholders express approval or disapproval of how executives are paid, but the board is not legally required to change anything based on the result.

The sharp drop in the stock price on the same day is not explained by the filing. The filing only reports the vote results; the price decline could be due to market factors, but the source does not say.

For a small-cap company like OSR Health (with a stock price around $0.29), share price moves can be large and are not always tied to company-specific news.